| South Eastern Eye Center, Office Of Dr Nacondus Gamble | |
|
345 Lindquist, Bldg. 71, Apo, AA 31314-0345 | |
| (912) 876-1101 | |
| (912) 877-4244 |
| Full Name | South Eastern Eye Center, Office Of Dr Nacondus Gamble |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 345 Lindquist, Apo, Armed Forces Americas |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093953002 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT002433 (Georgia) | Primary |
| Provider Name | Nacondus G Gamble |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1861402588 PECOS PAC ID: 4880693571 Enrollment ID: I20080902000285 |
News Archive
CONRAD is pleased to join in congratulating the Global iPrEx study team for their successful trial of oral tenofovir (TDF) with emtricitabine (FTC) for HIV prevention.
iMedX Inc., a leading healthcare software and services company, announced today that it has completed the acquisition of the assets of Accumed Script Inc. With this acquisition, iMedX adds Accumed's many clinics in Ohio to its customer base.
Interleukin Genetics, Inc. and NYU Langone Medical Center announced findings from a study performed in collaboration with Duke University on the genetics of osteoarthritis have been published this week in the "Online First" version of the Annals of Rheumatic Diseases and is available at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf.
The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain. Making such a universal influenza vaccine is feasible but licensing it may require innovation on several fronts, including finding new ways to evaluate the efficacy of vaccine candidates in clinical trials, conclude scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
A Chilean hospital's early use of antiviral treatment in influenza patients and other aggressive measures helped reduce the number of severe H1N1 cases and related deaths. Those are the findings of a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650750), published in the March 15, 2010 issue of Clinical Infectious Diseases.
› Verified 4 days ago
| Provider Name | Robin Cone |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1457443277 PECOS PAC ID: 1951538933 Enrollment ID: I20131219000530 |
News Archive
CONRAD is pleased to join in congratulating the Global iPrEx study team for their successful trial of oral tenofovir (TDF) with emtricitabine (FTC) for HIV prevention.
iMedX Inc., a leading healthcare software and services company, announced today that it has completed the acquisition of the assets of Accumed Script Inc. With this acquisition, iMedX adds Accumed's many clinics in Ohio to its customer base.
Interleukin Genetics, Inc. and NYU Langone Medical Center announced findings from a study performed in collaboration with Duke University on the genetics of osteoarthritis have been published this week in the "Online First" version of the Annals of Rheumatic Diseases and is available at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf.
The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain. Making such a universal influenza vaccine is feasible but licensing it may require innovation on several fronts, including finding new ways to evaluate the efficacy of vaccine candidates in clinical trials, conclude scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
A Chilean hospital's early use of antiviral treatment in influenza patients and other aggressive measures helped reduce the number of severe H1N1 cases and related deaths. Those are the findings of a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650750), published in the March 15, 2010 issue of Clinical Infectious Diseases.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| South Eastern Eye Center, Office Of Dr Nacondus Gamble Po Box 3700, Fort Stewart, GA 31315-3700 Ph: (912) 748-3926 | South Eastern Eye Center, Office Of Dr Nacondus Gamble 345 Lindquist, Bldg. 71, Apo, AA 31314-0345 Ph: (912) 876-1101 |
News Archive
CONRAD is pleased to join in congratulating the Global iPrEx study team for their successful trial of oral tenofovir (TDF) with emtricitabine (FTC) for HIV prevention.
iMedX Inc., a leading healthcare software and services company, announced today that it has completed the acquisition of the assets of Accumed Script Inc. With this acquisition, iMedX adds Accumed's many clinics in Ohio to its customer base.
Interleukin Genetics, Inc. and NYU Langone Medical Center announced findings from a study performed in collaboration with Duke University on the genetics of osteoarthritis have been published this week in the "Online First" version of the Annals of Rheumatic Diseases and is available at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf.
The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain. Making such a universal influenza vaccine is feasible but licensing it may require innovation on several fronts, including finding new ways to evaluate the efficacy of vaccine candidates in clinical trials, conclude scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
A Chilean hospital's early use of antiviral treatment in influenza patients and other aggressive measures helped reduce the number of severe H1N1 cases and related deaths. Those are the findings of a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650750), published in the March 15, 2010 issue of Clinical Infectious Diseases.
› Verified 4 days ago
Dr. Robert Andrew Hillstead, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 697 Louisiana Drive, Apo, AA 79606 Phone: 325-696-4677 | |
Kyle Eryn Hall, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: General Leonard Wood Army Community Hospital (glwach), Apo, AA 65584 Phone: 573-596-0035 |